|
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial |
|
|
|
Titel: |
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial |
Auteur: |
Vlaar, Alexander P J Witzenrath, Martin van Paassen, Pieter Heunks, Leo M A Mourvillier, Bruno de Bruin, Sanne Lim, Endry H T Brouwer, Matthijs C Tuinman, Pieter R Saraiva, José F K Marx, Gernot Lobo, Suzana M Boldo, Rodrigo Simon-Campos, Jesus A Cornet, Alexander D Grebenyuk, Anastasia Engelbrecht, Johannes M Mukansi, Murimisi Jorens, Philippe G Zerbib, Robert Rückinger, Simon Pilz, Korinna Guo, Renfeng van de Beek, Diederik Riedemann, Niels C |
Verschenen in: |
Lancet respiratory medicine |
Paginering: |
Jaargang 10 () nr. 12 pagina's 1137-1146 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|